Nephron. 2020 Mar 23:1-9. doi: 10.1159/000507305. [Epub ahead of print]
Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.
Perico L1, Benigni A1, Remuzzi G2,3.
Author information
Abstract
Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.
? 2020 S. Karger AG, Basel.
KEYWORDS:
Angiotensin receptor blockers; Angiotensin-converting enzyme inhibitors; COVID-19; Renal and cardiac side effects; SARS-CoV-2; Severe acute respiratory syndrome coronavirus
PMID:32203970DOI:10.1159/000507305